ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,326.59
0.18%
Dow Jones
43,914.12
-0.53%
Gold vs US Dollar
2,684.165
0.13%
Brent Oil
73.38
0.23%
Bitcoin
100,226.81
0.17%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) News

Alvontech (ALVO)

Alvontech
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALVO
DateTimeSourceHeadlineSymbolCompany
13/11/202421:05GlobeNewswire Inc.Alvotech Reports Financial Results for the First Nine Months of 2024NASDAQ:ALVOAlvontech
07/11/202413:00GlobeNewswire Inc.Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024NASDAQ:ALVOAlvontech
04/11/202412:00GlobeNewswire Inc.European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)NASDAQ:ALVOAlvontech
30/10/202412:30GlobeNewswire Inc.Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ETNASDAQ:ALVOAlvontech
25/10/202412:00GlobeNewswire Inc.Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024NASDAQ:ALVOAlvontech
22/10/202411:00GlobeNewswire Inc.Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)NASDAQ:ALVOAlvontech
10/10/202409:00GlobeNewswire Inc.European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®NASDAQ:ALVOAlvontech
25/09/202409:00GlobeNewswire Inc.Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®NASDAQ:ALVOAlvontech
26/08/202413:14GlobeNewswire Inc.Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:ALVOAlvontech
16/08/202409:57IH Market NewsH&R Block Shares Surge 10% on Profit and Dividend Boost, Applied Materials Drops 3% Despite Strong Earnings, Latest in EarningsNASDAQ:ALVOAlvontech
15/08/202420:15GlobeNewswire Inc.Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024NASDAQ:ALVOAlvontech
15/08/202410:09IH Market NewsU.S. Futures Rise on Easing Inflation, Oil Prices RiseNASDAQ:ALVOAlvontech
15/08/202408:30GlobeNewswire Inc.European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)NASDAQ:ALVOAlvontech
01/08/202420:02GlobeNewswire Inc.Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ETNASDAQ:ALVOAlvontech
22/07/202410:30GlobeNewswire Inc.STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across EuropeNASDAQ:ALVOAlvontech
11/07/202408:45GlobeNewswire Inc.Alvotech Announces Closing of Private Debt FinancingNASDAQ:ALVOAlvontech
02/07/202413:00GlobeNewswire Inc.Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®NASDAQ:ALVOAlvontech
01/07/202421:35GlobeNewswire Inc.Alvotech Issues New Shares to Holders of Convertible BondsNASDAQ:ALVOAlvontech
01/07/202409:10GlobeNewswire Inc.Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024NASDAQ:ALVOAlvontech
26/06/202408:50GlobeNewswire Inc.Alvotech Receives Conversion Notices for Majority of Convertible BondsNASDAQ:ALVOAlvontech
18/06/202408:01GlobeNewswire Inc.Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in EuropeNASDAQ:ALVOAlvontech
11/06/202408:00GlobeNewswire Inc.Alvotech and STADA add to strategic alliance through denosumab partnershipNASDAQ:ALVOAlvontech
07/06/202408:00GlobeNewswire Inc.Alvotech Announces Strategic Refinancing AgreementNASDAQ:ALVOAlvontech
29/05/202412:05GlobeNewswire Inc.Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024NASDAQ:ALVOAlvontech
21/05/202421:15GlobeNewswire Inc.Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business UpdateNASDAQ:ALVOAlvontech
21/05/202414:05Business WireAlvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UKNASDAQ:ALVOAlvontech
21/05/202412:00GlobeNewswire Inc.Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UKNASDAQ:ALVOAlvontech
21/05/202411:13IH Market NewsU.S. Index Futures Open Lower Amid Nasdaq Record, Fed SpeechesNASDAQ:ALVOAlvontech
21/05/202400:25Business WireTeva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.NASDAQ:ALVOAlvontech
21/05/202400:25GlobeNewswire Inc.Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.NASDAQ:ALVOAlvontech
 Showing the most relevant articles for your search:NASDAQ:ALVO

Your Recent History

LSE
TXP
Touchstone Exploration
LSE
BOO
Boohoo
LSE
VRS
Versarien
LSE
POS
Plexus
LSE
OMI
Orosur Mining
LSE
NFDS
Northern Foods
LSE
GLEN
Glencore
LSE
GOLD
LSE
HE1
Helium One Global
LSE
GGP
Greatland Gold
LSE
BARC
Barclays
LSE
PANR
Pantheon Resources
LSE
THG
Thg
LSE
ASC
Asos
LSE
APTA
Aptamer
LSE
TLW
Tullow Oil
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved